Price
1.41
+3.67%52W Range
Market Cap
₹48.85 Cr
Traded: ₹0.03 Cr (0.06%) 0.0x
Free Float: ₹22.78 Cr (0.12% of FF traded)
Volume · 60D trend
1.96 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | +5.0% | +21.0% | -3.0% | -- | +1.0% | Stable |
| Profit | +8.0% | +38.0% | +44.0% | -- | +110.0% | Accelerating |
| Return | +8.0% | +1.0% | -1.0% | -41.0% | -- | Decelerating |
| ROE | +0.0% | -2.0% | -3.0% | -- | -- | Decelerating |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2 | 2 | 4 | 8 | 8 | 7 | 6 | 5 | 3 | 4 | 3 | 4 | 3 | 10 | 4 | 5 |
| Expenses | 2 | 6 | 4 | 7 | 7 | 4 | 6 | 19 | 3 | 4 | 3 | 3 | 3 | 16 | 3 | 4 |
| Operating Profit | -0 | -4 | 0 | 0 | 1 | 3 | 0 | -15 | 0 | -1 | 0 | 1 | 0 | -7 | 2 | 1 |
| OPM % | -16.4% | -252.8% | 5.3% | 3.7% | 9.0% | 42.8% | 8.0% | -321.8% | 11.5% | -15.4% | 11.4% | 17.1% | 14.8% | -67.7% | 33.9% | 14.1% |
| Other Income | 1 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 5 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 0 | 0 | 1 | 3 | 1 | -14 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 0 |
| Tax % | 0.0% | -150.0% | 20.0% | 33.3% | 25.0% | 0.0% | 0.0% | -0.3% | 14.8% | 0.0% | -12.0% | 26.1% | 13.8% | -13.0% | 28.0% | 0.0% |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 3 | 1 | -14 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 0 |
| Exceptional Items | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| EPS (Rs) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | -0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.1 | 0.1 |
| Sales Growth (YoY) | -73.0% | -77.0% | -28.0% | 64.0% | 123.0% | 100.0% | 76.0% | 31.0% | 15.0% | -64.0% | -23.0% | -25.0% | -34.0% | -- | -- | -- |
| Sales Growth (QoQ) | -- | -63.0% | -42.3% | -2.7% | 10.6% | 16.6% | 30.9% | 31.9% | -0.6% | 2.3% | -2.3% | 15.5% | -68.8% | 117.7% | -4.9% | -- |
| OP Growth (YoY) | -148.6% | -235.7% | -52.1% | 101.9% | 75.0% | 655.6% | 23.1% | -2561.7% | -11.1% | 91.8% | -74.2% | -9.1% | -- | -- | -- | -- |
| OP Growth (QoQ) | 91.6% | -1869.6% | -17.9% | -60.0% | -76.7% | 525.0% | 103.2% | -3792.5% | 174.1% | -238.5% | -35.0% | 33.3% | 106.8% | -535.1% | 128.8% | -- |
| Profit Growth (YoY) | -- | -96.0% | -62.0% | 101.0% | 135.0% | 30100.0% | 85.0% | -4300.0% | -8.0% | 101.0% | -72.0% | -29.0% | -58.0% | -137.0% | 296.0% | 100.0% |
| EPS Growth (YoY) | -- | -100.0% | -50.0% | 102.2% | 100.0% | -- | 0.0% | -1600.0% | -50.0% | 100.0% | -77.8% | -40.0% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -- | -100.0% | 0.0% | -50.0% | -77.8% | 350.0% | 104.4% | -4600.0% | -- | -100.0% | -33.3% | 50.0% | 113.3% | -266.7% | 80.0% | -- |
| OP Margin | -- | -252.8% | 5.3% | 3.7% | 9.0% | 42.8% | 8.0% | -321.8% | 11.5% | -15.4% | 11.4% | 17.1% | 14.8% | -67.7% | 33.9% | 14.1% |
| Net Margin | -- | 6.8% | 4.4% | 2.8% | 7.0% | 43.1% | 8.3% | -311.1% | 6.6% | 0.3% | 7.9% | 9.7% | 8.3% | -17.1% | 21.3% | 10.2% |
| Material Cost % | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Employee Cost % | -- | 293.0% | 86.0% | 92.0% | 87.0% | 78.0% | 89.0% | 89.0% | 82.0% | 96.0% | 77.0% | 73.0% | 71.0% | 165.0% | 55.0% | 60.0% |
| P/S | 3.14 | 2.49 | 2.61 | 3.30 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 47.00 | 38.25 | 15.46 | 19.29 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 0.40 | 0.44 | 0.62 | 0.83 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50We are her with submitting the News Paper Publication of Unaudited Financial Results (Standalone & Consolidated) for the period ended 30th June 2026 in the following news papers in today''s ....
The Board at its meeting held on 11-08-2026 approved the unaudited quarterly financial results (standalone & Consolidateda) for the period ended 30-06-2026
Intimation attached
Intimation attached
Annual Secretarial compliance report for the FY 2025-26
Intimation attached
Audited financial results for the quarter and year ended 31 March 2026
Outcome of the Board Meeting held on 27 May 2026.
Orchasp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve 1. To consider the recommendations ....
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Zeal Global Opportunities Fund - FCCB
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Intimation attached
Disclosure pursuant to Regulation 30 of SEBI(LODR) read with sub paragraph 8 of paragraph B of part A of Schedule III to LODR Regulations
Closure of Trading Window
Intimation attached
Outcome of the Board Meeting held on 06th March 2026.
We would like to inform that the company''s electronic health records platform INDUSAYUSH has been admitted on apple app store with effect from February 24. 2026
Intimation attached
Intimation attached
Intimation attached
Financial Results for the quarter and nine months ended 31 December 2025
Outcome Of The Board Meeting Held On 10 February 2026
Orchasp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 ,inter alia, to consider and approve (a) Unaudited Quarterly Financial Results ....
Intimation attached
We are herewith submitting our clarification with regard to the query raised by listing compliance team for delay in submission of announcement of material event
We would like to inform that the company''s electronic health records platform INDUSAYUSH has been admitted on google playstore with effect from December 31,2025
The trading window for dealing in securities of the company for the promoters, directors, designated persons, shall remain closed from the 01st of January 2026 until completion of 48 hours ....
The Board has approved allotment of 2,68,75,000 Equity Shares of Rs.2/- each to Ms.Rajeswari Pattapurathi for an issue Price of Rs.3.20 each
Orchasp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/12/2025 ,inter alia, to consider and approve (a) Allotment of 2,68,75,000 Equity ....
The Company has received an In Principle - Prior Approval for allotment of 2,68,75,000 Equity shares to allottee on a Preferential Allotment basis from BSE Limited and NSE of India Limited
The Company has incorporated a new Wholly Owned Subsidiary viz Orchasp Inc in USA
We are submitting the copies of the News Paper Publication of the Unaudited Quarterly and Half Yearly Financial Results (Standalone & Consolidated) in Business Standard and Nava Telangana ....
The Board has approved the Unaudited Quarterly Financial Results (Standalone & Consolidated) for the second quarter and half year ended 30th September 2025
Orchasp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2025 ,inter alia, to consider and approve (a) Unaudited financial results (standalone ....
We are herewith submitting the certificate of compliance pursuant to Regulation 74(5) pf SEBI(Depositaries and Participants) Regulations,2018 for the second quarter and half year ended 30-09-2025
We are herewith attaching the Voting Results and Scrutinizer''s Report for the e voting for the 31st Annual General Meeting of the Company held on 30th September 2025
We are herewith intimating the closure of trading window for the quarter and half year ended 30th September 2025, in accordance with the SEBI(PIT) Regulations 2015with effect from 01-10-2025 ....
We are submitting the summary of the proceedings of the 31st Annual General Meeting held today i.e the 30th September 2025 at 10.30 am through VC/OAVM
Notice of 31st Annual General Meeting published in Business standard and Nava Telangana on 24-09-2025
We are resubmitting the 31st Annual Report are giving effect to the corrections in explanatory statement to Notice of the AGM
We are herewith submitting the copies of Corrigendum to Explanatory Statement to the 31st Annual General Meeting of the Company published in Business Standard (English) and Nava Telangana ....
We are herewith submitting the 31st Annual Report of the company in complliance with Regulation 34(1) of SEBI(LODR) Regulations,2015
We wish to update on the correction in the record date for the 31st AGM which was erroneously mentioned in the outcome and hence the submission of rejoinder
Rejoinder of the board meeting to include the resolution for re-appointment of Mr. Chandra Sekhar Pattapurathi(DIN : 01647212) as Managing Director & CFO, subject, however to the approval ....
The Board has approved Notice to the 31st Annual General Meeting and related resolutions to be considered at the 31st Annual General Meeting.
Orchasp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2025 ,inter alia, to consider and approve the Notice of 31st AGM and related resolutions
Pursuant to Regulation 30(2) and 33 read with Part A of Schedule III of SEBI (LODR) Regulation, 2015, we hereby intimate your good selves that the Board of Directors of the Company at its ....
Orchasp Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2025 ,inter alia, to consider and approve the unaudited quarterly financial results( ....
Intimation attached
We are herewith submitting our intimation of trading window closure with effect from 01-07-2025 till 48 hours after declaration of Unaudited Financial Results (Standalone & Consolidated) ....